Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump

Credit: CBS 2 New York

Duration: 02:15s 08 Oct 2020 0 shares 3 views

Regeneron Seeks FDA's Emergency Use Authorization For COVID-19 Antibody Treatment Given To President Trump

Pres.

Donald Trump credits drug maker Regeneron's treatment for relieving his COVID-19 symptoms. But, what is it, and how might you get it?

CBS2's Meg Baker reports.

You might like

Related news coverage

Regeneron says its COVID-19 drug cut patient visits

Regeneron says its COVID-19 drug cut patient visits

Reuters - Politics 29 Oct 2020

Regeneron said on Wednesday its coronavirus antibody cocktail - used to treat U.S. President Donald Trump - significantly reduced..

FDA approves first drug as treatment for COVID-19

FDA approves first drug as treatment for COVID-19

WTHI

26 Oct 2020

Eli Lilly pauses trial of antibody drug over safety concern

Eli Lilly pauses trial of antibody drug over safety concern

Reuters - Politics

13 Oct 2020

Covid Treatments At Mayo Clinic

Covid Treatments At Mayo Clinic

KIMT

09 Oct 2020

Dr. Ali Hassoun On The President's Diagnosis

Dr. Ali Hassoun On The President's Diagnosis

WAAY ABC Huntsville, AL

09 Oct 2020

Advertisement

More coverage

Reporter Update: New Coronavirus Antibody Cocktail Seeking Emergency Use Authorization

Reporter Update: New Coronavirus Antibody Cocktail Seeking Emergency Use Authorization

KDKA CBS 2 Pittsburgh 08 Oct 2020

KDKA's Dr. Maria Simbra has more on a new antibody cocktail for coronavirus seeking emergency use authorization through the FDA.

Tucson clinic part of trial for Pres. Trump's treatment

Tucson clinic part of trial for Pres. Trump's treatment

KGUN, Tucson, AZ

06 Oct 2020

Dr. Joseph Fair explains the medicine given to President Trump to combat COVID-19

Dr. Joseph Fair explains the medicine given to President Trump to combat COVID-19

TODAY’S TMJ4

02 Oct 2020